These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 21245437)

  • 1. Vaginal microbicide gel for delivery of IQP-0528, a pyrimidinedione analog with a dual mechanism of action against HIV-1.
    Mahalingam A; Simmons AP; Ugaonkar SR; Watson KM; Dezzutti CS; Rohan LC; Buckheit RW; Kiser PF
    Antimicrob Agents Chemother; 2011 Apr; 55(4):1650-60. PubMed ID: 21245437
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vaginal film drug delivery of the pyrimidinedione IQP-0528 for the prevention of HIV infection.
    Ham AS; Rohan LC; Boczar A; Yang L; W Buckheit K; Buckheit RW
    Pharm Res; 2012 Jul; 29(7):1897-907. PubMed ID: 22392331
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety and efficacy of tenofovir/IQP-0528 combination gels - a dual compartment microbicide for HIV-1 prevention.
    Dezzutti CS; Shetler C; Mahalingam A; Ugaonkar SR; Gwozdz G; Buckheit KW; Buckheit RW
    Antiviral Res; 2012 Nov; 96(2):221-5. PubMed ID: 22940075
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of a combination microbicide gel formulation containing IQP-0528 and tenofovir for the prevention of HIV infection.
    Ham AS; Ugaonkar SR; Shi L; Buckheit KW; Lakougna H; Nagaraja U; Gwozdz G; Goldman L; Kiser PF; Buckheit RW
    J Pharm Sci; 2012 Apr; 101(4):1423-35. PubMed ID: 22227864
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safe and sustained vaginal delivery of pyrimidinedione HIV-1 inhibitors from polyurethane intravaginal rings.
    Johnson TJ; Srinivasan P; Albright TH; Watson-Buckheit K; Rabe L; Martin A; Pau CP; Hendry RM; Otten R; McNicholl J; Buckheit R; Smith J; Kiser PF
    Antimicrob Agents Chemother; 2012 Mar; 56(3):1291-9. PubMed ID: 22155820
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The rational design and development of a dual chamber vaginal/rectal microbicide gel formulation for HIV prevention.
    Ham AS; Nugent ST; Peters JJ; Katz DF; Shelter CM; Dezzutti CS; Boczar AD; Buckheit KW; Buckheit RW
    Antiviral Res; 2015 Aug; 120():153-64. PubMed ID: 26093158
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety and Pharmacokinetics of Quick-Dissolving Polymeric Vaginal Films Delivering the Antiretroviral IQP-0528 for Preexposure Prophylaxis.
    Srinivasan P; Zhang J; Martin A; Kelley K; McNicholl JM; Buckheit RW; Smith JM; Ham AS
    Antimicrob Agents Chemother; 2016 Jul; 60(7):4140-50. PubMed ID: 27139475
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of gel volume on pharmacokinetics for vaginal and rectal applications of combination DuoGel-IQB4012, a dual chamber-dual drug HIV microbicide gel, in pigtailed macaques.
    Pereira LE; Singletary T; Martin A; Dinh CT; Deyounks F; Holder A; McNicholl J; Buckheit KW; Buckheit RW; Ham A; Katz DF; Smith JM
    Drug Deliv Transl Res; 2018 Oct; 8(5):1180-1190. PubMed ID: 29761350
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development and in vitro evaluation of a vaginal microbicide gel formulation for UAMC01398, a novel diaryltriazine NNRTI against HIV-1.
    Grammen C; Ariën KK; Venkatraj M; Joossens J; Van der Veken P; Heeres J; Lewi PJ; Haenen S; Augustyns K; Vanham G; Augustijns P; Brouwers J
    Antiviral Res; 2014 Jan; 101():113-21. PubMed ID: 24269474
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vaginal deployment and tenofovir delivery by microbicide gels.
    Gao Y; Yuan A; Chuchuen O; Ham A; Yang KH; Katz DF
    Drug Deliv Transl Res; 2015 Jun; 5(3):279-94. PubMed ID: 25874971
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development and characterization of a solid dispersion film for the vaginal application of the anti-HIV microbicide UAMC01398.
    Grammen C; Van den Mooter G; Appeltans B; Michiels J; Crucitti T; Ariën KK; Augustyns K; Augustijns P; Brouwers J
    Int J Pharm; 2014 Nov; 475(1-2):238-44. PubMed ID: 25175729
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Non-aqueous silicone elastomer gels as a vaginal microbicide delivery system for the HIV-1 entry inhibitor maraviroc.
    Forbes CJ; Lowry D; Geer L; Veazey RS; Shattock RJ; Klasse PJ; Mitchnick M; Goldman L; Doyle LA; Muldoon BC; Woolfson AD; Moore JP; Malcolm RK
    J Control Release; 2011 Dec; 156(2):161-9. PubMed ID: 21864598
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetic and Pharmacodynamic Evaluation following Vaginal Application of IQB3002, a Dual-Chamber Microbicide Gel Containing the Nonnucleoside Reverse Transcriptase Inhibitor IQP-0528 in Rhesus Macaques.
    Pereira LE; Mesquita PM; Ham A; Singletary T; Deyounks F; Martin A; McNicholl J; Buckheit KW; Buckheit RW; Smith JM
    Antimicrob Agents Chemother; 2015 Dec; 60(3):1393-400. PubMed ID: 26666935
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Examining the Safety, Pharmacokinetics, and Pharmacodynamics of a Rectally Administered IQP-0528 Gel for HIV Pre-Exposure Prophylaxis: A First-In-Human Study.
    Al-Khouja A; Shieh E; Fuchs EJ; Marzinke MA; Bakshi RP; Hummert P; Ham AS; Buckheit KW; Breakey J; Weld ED; Chen H; Caffo BS; Buckheit RW; Hendrix CW
    AIDS Res Hum Retroviruses; 2021 Jun; 37(6):444-452. PubMed ID: 33371779
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Formulation development and evaluation of innovative two-polymer (SR-2P) bioadhesive vaginal gel.
    Podaralla S; Alt C; Shankar GN
    AAPS PharmSciTech; 2014 Aug; 15(4):928-38. PubMed ID: 24781671
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An Intravaginal Ring for the Simultaneous Delivery of an HIV-1 Maturation Inhibitor and Reverse-Transcriptase Inhibitor for Prophylaxis of HIV Transmission.
    Ugaonkar SR; Clark JT; English LB; Johnson TJ; Buckheit KW; Bahde RJ; Appella DH; Buckheit RW; Kiser PF
    J Pharm Sci; 2015 Oct; 104(10):3426-39. PubMed ID: 26149293
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro and ex vivo evaluations on transdermal delivery of the HIV inhibitor IQP-0410.
    Ham AS; Lustig W; Yang L; Boczar A; Buckheit KW; Buckheit RW
    PLoS One; 2013; 8(9):e75306. PubMed ID: 24058672
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modified silicone elastomer vaginal gels for sustained release of antiretroviral HIV microbicides.
    Forbes CJ; McCoy CF; Murphy DJ; Woolfson AD; Moore JP; Evans A; Shattock RJ; Malcolm RK
    J Pharm Sci; 2014 May; 103(5):1422-32. PubMed ID: 24585370
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Semi-solid gels function as physical barriers to human immunodeficiency virus transport in vitro.
    Lai BE; Geonnotti AR; Desoto MG; Montefiori DC; Katz DF
    Antiviral Res; 2010 Nov; 88(2):143-51. PubMed ID: 20709109
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Dose Ranging Pharmacokinetic Evaluation of IQP-0528 Released from Intravaginal Rings in Non-Human Primates.
    Su JT; Teller RS; Srinivasan P; Zhang J; Martin A; Sung S; Smith JM; Kiser PF
    Pharm Res; 2017 Oct; 34(10):2163-2171. PubMed ID: 28770490
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.